Companies Dominating the Non-opioid Pain Patch Market
- Sanofi S.A.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GlaxoSmithKline Plc.
- Pfizer Inc.
- Clarion Brands
- Endo Pharmaceuticals
- TEH SENG Pharmaceutical
- Teva Pharmaceutical Industries Ltd.
- Teikoku Seiyaku Co. Ltd.
- Veridian Healthcare
- Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Non-opioid Pain Patch Market in 2025 is evaluated at USD 3.74 billion.
The global market size was over USD 3.61 billion in 2024 and is anticipated to witness a CAGR of more than 4.4%, crossing USD 6.32 billion revenue by 2037.
North America is projected to garner USD 3.22 billion by 2037, attributed to presence of key players leading to development of new products.
The major players in the market include GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
